Trial Profile
Evaluation of amino acid substitution of hepatitis C virus as a treatment efficacy and predictive factor
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Telaprevir (Primary) ; Peginterferon; Peptide hydrolase inhibitors; Ribavirin
- Indications Hepatitis C
- Focus Pharmacodynamics
- 23 Dec 2015 New trial record